Benjamin Bitler, Ph.D., a postdoctoral fellow in the lab of Rugang Zhang, Ph.D., talks about exciting work involving ARID1A, a chromatin remodeler and an ideal target in a very difficult-to-treat form of ovarian cancer.
Music: "Elements" by ThatBeat (Licensed under Creative Commons Attribution 3.0)
Ovarian Cancer Subtypes image, Copyright 2013 The American Association of Cancer Research
Other images provided by Zhang laboratory at The Wistar Institute.